Fig. 1From: Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney diseaseSerum TSP-2 levels and other clinical risk factors for the identification of DN in study participants with T2DM (n = 494)Back to article page